metastatic colorectal cancer

Open Access
Conversion Surgery After Encorafenib Plus Cetuximab for Chemorefractory BRAF V600E-mutated Colorectal Cancer With Para-aortic Lymph Node Metastases
AYANE KAWATA, YUJI MIYAMOTO, KOTARO FUKUBAYASHI, TAKATO HORIO, HIDEAKI MIYAMOTO, KATSUHIRO OGAWA, MAYUKO OUCHI, YASUHITO TANAKA and HIDEO BABA

In Vivo July 2023, 37 (4) 1797-1801; DOI: https://doi.org/10.21873/invivo.13269
You have access
An Independent Validation Study of Candidate microRNAs as Predictive Biomarkers for Bevacizumab-based Therapy in Patients With Metastatic Colorectal Cancer
DAVID KISS, TANA MACHACKOVA, KAMILA SOUCKOVA, PAVEL FABIAN, IVETA KREPELKOVA, MAREK SVOBODA and IGOR KISS

In Vivo September 2021, 35 (5) 2809-2814; DOI: https://doi.org/10.21873/invivo.12567
You have access
Prognostic Role of the Platelet-to-Lymphocyte Ratio for Patients With Metastatic Colorectal Cancer Treated With Aflibercept
AKIHISA MATSUDA, TAKESHI YAMADA, SATOSHI MATSUMOTO, SEIICHI SHINJI, RYO OHTA, HIROMICHI SONODA, ERIKO SHINOZUKA, KUMIKO SEKIGUCHI, HIDEYUKI SUZUKI and HIROSHI YOSHIDA

In Vivo September 2020, 34 (5) 2667-2673; DOI: https://doi.org/10.21873/invivo.12086
You have access
CA19-9 Concentration After First-line Chemotherapy Is Prognostic Predictor of Metastatic Colon Cancer
RYOSUKE HASHIZUME, HIDEJIRO KAWAHARA, MASAICHI OGAWA, KATSUHITO SUWA, KEN ETO and KATSUHIKO YANAGA

In Vivo November 2019, 33 (6) 2087-2093; DOI: https://doi.org/10.21873/invivo.11708
You have access
Severe Encephalopathy, Lactic Acidosis and Hyperammonaemia With FOLFIRI Plus Aflibercept After Two-stage Hepatectomy: A Case Report
YOSHIHIRO HARA, YUJI MIYAMOTO, YUKIHARU HIYOSHI, MASAAKI IWATSUKI, YOSHIFUMI BABA, NAOYA YOSHIDA and HIDEO BABA

In Vivo March 2019, 33 (2) 563-565; DOI: https://doi.org/10.21873/invivo.11511

Main menu

User menu

Search

metastatic colorectal cancer